
CAPRICOR THERAPEUTICS INC
CAPRNASDAQTrading Snapshot
- Day Range
- $3.87 β $3.98
- 52-Week Range
- $2.96 β $40.37
- Volume
- $2.91B
- Avg Volume
- $3.63B
- Shares Outstanding
- 57.9M
- Next Earnings
- Sep 6, 2026
Fundamentals Snapshot
- Annual Revenue
- $23M
- Last Q Revenue
- $6M
- P/E Ratio
- β
- P/S Ratio
- 10.0x
- EPS (TTM)
- $-2.31
- Dividend Yield
- β
Why Investors Own CAPR
- βHigh-growth profile β revenue up -9.5% YoY with expanding US Equity exposure.
- βHealthy economics β 75% gross margin and 18% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About CAPRICOR THERAPEUTICS INC
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (βDMDβ), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Otter Score Breakdown
βAnalyst Ratings
βLatest News & Updates

Cisco, Tencent Headline Muted Earnings Week
Wall Street Week Ahead: key market events, CPI/retail data, earnings (Cisco, Tencent), IPOs & dividends after weak jobs report. See more details here.

Benzinga Bulls And Bears: Amazon, Microsoft, SpaceX
Benzinga examined the prospects for many investorsβ favorite stocks over the last week β hereβs a look at some of our top stories.

The trading volume of these stocks is deviating from the norm in today's session.
Which stocks have an unusual volume on Friday?

Replimune Skin Cancer Therapy Hopes Revive After Positive FDA Panel Vote
FDA advisory panel backed Replimune's RP1 melanoma data ahead of the agency's August 2 decision despite earlier staff criticism.

Here are the top movers in Thursday's session.
Wondering how the US markets performed one hour before the close of the markets on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.

Let's uncover which stocks are experiencing notable gaps during today's session.
The session on Thursday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.